ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $481,009,000 | -1.5% | 18,716,306 | 0.0% | 4.77% | +37.1% |
| Q2 2021 | $488,121,000 | -26.1% | 18,716,306 | 0.0% | 3.48% | -54.9% |
| Q1 2021 | $660,686,000 | +39.9% | 18,716,306 | 0.0% | 7.71% | +47.3% |
| Q4 2020 | $472,400,000 | -33.1% | 18,716,306 | 0.0% | 5.23% | -58.6% |
| Q3 2020 | $705,792,000 | -16.4% | 18,716,306 | -5.1% | 12.65% | -15.2% |
| Q2 2020 | $844,252,000 | +104.7% | 19,716,306 | -7.1% | 14.91% | +56.9% |
| Q1 2020 | $412,445,000 | -25.2% | 21,216,306 | 0.0% | 9.50% | +16.9% |
| Q4 2019 | $551,200,000 | -52.3% | 21,216,306 | -50.0% | 8.13% | -4.8% |
| Q3 2019 | $1,156,500,000 | +103.0% | 42,432,612 | +100.0% | 8.54% | -0.4% |
| Q2 2019 | $569,658,000 | -14.8% | 21,216,306 | -8.3% | 8.58% | -34.8% |
| Q1 2019 | $668,835,000 | +7.4% | 23,135,061 | 0.0% | 13.15% | +30.7% |
| Q4 2018 | $623,027,000 | – | 23,135,061 | – | 10.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |